Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
Cynthia X Ma, Ron Bose, Feng Gao, et al.
The Lancet. Oncology
|
March 19, 2019
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
Panagiotis A Konstantinopoulos, William T Barry, Michael Birrer, et al.
Nature Medicine
|
June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Cancer
|
May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
April C Watt, Paloma Cejas, Molly J DeCristo, et al.
JAMA Oncology
|
August 8, 2024
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial
Julia S Wong, Hajime Uno, Angela C Tramontano, et al.
JAMA
|
December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial
E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
NPJ Breast Cancer
|
July 27, 2021
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
Jane Bayani, Coralie Poncet, Cheryl Crozier, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosis
Jooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
NPJ Breast Cancer
|
May 11, 2026
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
Yara Abdou, Mariya Rozenblit, Dario Trapani, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
Cynthia X Ma, Ron Bose, Feng Gao, et al.
The Lancet. Oncology
|
March 19, 2019
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
Panagiotis A Konstantinopoulos, William T Barry, Michael Birrer, et al.
Nature Medicine
|
June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Cancer
|
May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
April C Watt, Paloma Cejas, Molly J DeCristo, et al.
JAMA Oncology
|
August 8, 2024
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial
Julia S Wong, Hajime Uno, Angela C Tramontano, et al.
JAMA
|
December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial
E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
NPJ Breast Cancer
|
July 27, 2021
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
Jane Bayani, Coralie Poncet, Cheryl Crozier, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosis
Jooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
NPJ Breast Cancer
|
May 11, 2026
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
Yara Abdou, Mariya Rozenblit, Dario Trapani, et al.
Page
of 11